{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:35:31Z","timestamp":1786739731517,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The aim was to assess the effect of vasopressin in reducing the time of surgery, amount of bleeding, and fluid deficit during hysteroscopic myomectomy of submucosal myoma from 2016 to 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>\n                      This study was conducted as a prospective, randomized, single-blinded clinical trial on the premenopausal women ranged from 18 to 62 years' old. A number of 80 patients were randomly assigned to each arm of the study according to random consecutive numbers. The control group (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 40) of patients underwent conventional hysteroscopic myomectomy without vasopressin and the case group (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 40) underwent hysteroscopic myomectomy with the injection of diluted vasopressin. Measured outcomes were time for myomectomy, fluid deficit, inflow volume, visual clarity, and postoperation hemoglobin level.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The mean time of myomectomy was 38.1 and 77.38 min in vasopressin and control groups, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). The mean inflow volume was 2800 and 4100 in vasopressin and control groups, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.029). The visual clarity score was 8.5 and 6.5 in the vasopressin and control groups, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The injection of vasopressin during hysteroscopic myomectomy is effective in the management of fluid deficit, time of surgery, and improvement of visual clarity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_70_20","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T06:32:05Z","timestamp":1630305125000},"page":"22","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["The Effect of Vasopressin during Hysteroscopic Myomectomy in Patients with Submucosal Myoma"],"prefix":"10.4103","volume":"10","author":[{"given":"Safoura","family":"Rouholamin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Haghshenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20240830","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ogc.2012.09.005","article-title":"The impact and management of fibroids for fertility: An evidence-based approach","volume":"39","author":"Guo","year":"2012","journal-title":"Obstet Gynecol Clin"},{"key":"R2-22-20240830","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00404-010-1531-0","article-title":"Reproductive outcome following hysteroscopic myomectomy in patients with infertility and recurrent abortions","volume":"282","author":"Roy","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"R3-22-20240830","doi-asserted-by":"crossref","first-page":"791248","DOI":"10.1155\/2012\/791248","article-title":"Complications of uterine fibroids and their management, surgical management of fibroids, laparoscopy and hysteroscopy versus hysterectomy, haemorrhage, adhesions, and complications","volume":"2012","author":"Mettler","year":"2012","journal-title":"Obstet Gynecol Int"},{"key":"R4-22-20240830","first-page":"35","article-title":"Myomectomy: Technique and current indications","volume":"66","author":"Wong","year":"2014","journal-title":"Minerva Ginecol"},{"key":"R6-22-20240830","first-page":"167","article-title":"AAGL practice report: Practice guidelines for the management of hysteroscopic distending media: (replaces hysteroscopic fluid monitoring guidelines","volume":"7","author":"Munro","year":"2000","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"R7-22-20240830","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijgo.2007.05.050","article-title":"A systematic review of randomized controlled trials to reduce hemorrhage during myomectomy for uterine fibroids","volume":"100","author":"Kongnyuy","year":"2008","journal-title":"Int J Gynecol Obstet"},{"key":"R8-22-20240830","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/AOG.0b013e3181954c44","article-title":"Cervical vasopressin compared with no premedication and blood loss during vaginal hysterectomy: A randomized controlled trial","volume":"113","author":"Ascher-Walsh","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R9-22-20240830","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejogrb.2015.10.003","article-title":"Use of vasopressin vs epinephrine to reduce haemorrhage during myomectomy: A randomized controlled trial","volume":"195","author":"Song","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R10-22-20240830","first-page":"419","article-title":"Effects of vasopressin administration during hysteroscopic surgery","volume":"39","author":"Corson","year":"1994","journal-title":"J Reprod Med"},{"key":"R11-22-20240830","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13063-018-2442-9","article-title":"The HYSTER study: The effect of intracervically administered terlipressin versus placebo on the number of gaseous emboli and fluid intravasation during hysteroscopic surgery: Study protocol for a randomized controlled clinical trial","volume":"19","author":"Overdijk","year":"2018","journal-title":"Trials"},{"key":"R12-22-20240830","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.jmig.2015.08.364","article-title":"Vasopressin myoma infiltration during hysteroscopic myomectomy","volume":"22","author":"Canseco-Lima","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"R13-22-20240830","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1016\/j.jmig.2016.08.461","article-title":"Intraoperative vasopressin injection during hysteroscopic myomectomy","volume":"23","author":"Ferguson","year":"2016","journal-title":"Journal of Minimally Invasive Gynecology"},{"key":"R14-22-20240830","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/AOG.0000000000000515","article-title":"Transcervical intralesional vasopressin injection compared with placebo in hysteroscopic myomectomy: A randomized controlled trial","volume":"124","author":"Wong","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R15-22-20240830","first-page":"736","article-title":"Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: Results regarding the degree of intramural extension","volume":"82","author":"Wamsteker","year":"1993","journal-title":"Obstet Gynecol"},{"key":"R16-22-20240830","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1471-0528.1994.tb11918.x","article-title":"Intramyometrial vasopressin as a haemostatic agent during myomectomy","volume":"101","author":"Frederick","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"R17-22-20240830","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0029-7844(96)00282-7","article-title":"The effect of dilute vasopressin solution on blood loss during operative hysteroscopy: A randomized controlled trial","volume":"88","author":"Phillips","year":"1996","journal-title":"Obstet Gynecol"},{"key":"R18-22-20240830","first-page":"614","article-title":"Direct injection of vasopressin during hysteroscopic myomectomy: A case report","volume":"59","author":"Holloran-Schwartz","year":"2014","journal-title":"J Reprod Med"},{"key":"R19-22-20240830","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.fertnstert.2019.09.016","article-title":"Perioperative nonhormonal pharmacological interventions for bleeding reduction during open and minimally invasive myomectomy: A systematic review and network meta-analysis","volume":"113","author":"Samy","year":"2020","journal-title":"Fertil Steril"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_70_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:32:02Z","timestamp":1786735922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_70_20"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_70_20","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}